Baclofen toxicity: Difference between revisions
(Text replacement - "AMS" to "altered mental status") |
(Text replacement - "OR" to "'''OR'''") |
||
| Line 8: | Line 8: | ||
*Drowziness, dizziness | *Drowziness, dizziness | ||
*Seizures, delirium, altered mental status, coma | *Seizures, delirium, altered mental status, coma | ||
*Bradycardia, hypotension OR hypertension, respiratory compromise | *Bradycardia, hypotension '''OR''' hypertension, respiratory compromise | ||
*Hypothermia | *Hypothermia | ||
Revision as of 23:38, 30 May 2017
Background
- Indications include MS, muscle spasticity pain
- GABAb receptor agonist
- Most excretion is renal
Clinical Features
- nausea and vomiting
- Drowziness, dizziness
- Seizures, delirium, altered mental status, coma
- Bradycardia, hypotension OR hypertension, respiratory compromise
- Hypothermia
Differential Diagnosis
Evaluation
- Diagnosis of exclusion
Management
- Activated charcoal for recent ingestion
- Supportive care:
- IV fluids, respiratory care
- Vasopressors for persistent hypotension
- Benzodiazepines for seizures
- Hemodialysis for very severe toxicity
Disposition
See Also
References
- Jung, M. “Baclofen Overdoses”. Maryland Poison Center, University of Maryland School of Pharmacy. www.mdpoison.com Accessed April 29th, 2014.
- Nicola Y Leung, Ian M Whyte, Geoffrey K Isbister Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas: 2006, 18(1);77-82